Search research articles
Contact Us
Filters
Showing results (131-140 of 164) with videos related to
Page
of 17
Sort By:
American Journal of Hematology
|
November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia
Daniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.
Haematologica
|
September 18, 2012
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research
Armand Keating, Gisela DaSilva, Waleska S Pérez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation
M Tomblyn, M Chen, M Kukreja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Leukemia
|
August 22, 2015
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
N M Kröger, J H Deeg, E Olavarria, et al.
Bone Marrow Transplantation
|
October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation
Zachariah DeFilipp, Shuli Li, David Avigan, et al.
Bone Marrow Transplantation
|
October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Cancer
|
December 4, 2014
Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation
Areej R El-Jawahri, Lara N Traeger, Kailyn Kuzmuk, et al.
Bone Marrow Transplantation
|
September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
British Journal of Haematology
|
July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission
Andrew M Brunner, Shuli Li, Amir T Fathi, et al.
Page
of 17
Search research articles
Search
Showing results (131-140 of 164) with videos related to
Sort By:
Page
of 17
American Journal of Hematology
|
November 10, 2017
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia
Daniel J DeAngelo, Andrew M Brunner, Lillian Werner, et al.
Haematologica
|
September 18, 2012
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research
Armand Keating, Gisela DaSilva, Waleska S Pérez, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantation
M Tomblyn, M Chen, M Kukreja, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 12, 2011
Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?
John T Horan, Brent R Logan, Manza-A Agovi-Johnson, et al.
Leukemia
|
August 22, 2015
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
N M Kröger, J H Deeg, E Olavarria, et al.
Bone Marrow Transplantation
|
October 17, 2019
A phase II study of reduced intensity double umbilical cord blood transplantation using fludarabine, melphalan, and low dose total body irradiation
Zachariah DeFilipp, Shuli Li, David Avigan, et al.
Bone Marrow Transplantation
|
October 17, 2019
Correction: Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
Cancer
|
December 4, 2014
Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation
Areej R El-Jawahri, Lara N Traeger, Kailyn Kuzmuk, et al.
Bone Marrow Transplantation
|
September 6, 2019
Worldwide Network for Blood and Marrow Transplantation (WBMT) perspective: the role of biosimilars in hematopoietic cell transplant: current opportunities and challenges in low- and lower-middle income countries
Ibrahim N Muhsen, Shahrukh K Hashmi, Dietger Niederwieser, et al.
British Journal of Haematology
|
July 20, 2016
Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission
Andrew M Brunner, Shuli Li, Amir T Fathi, et al.
Page
of 17